InvestorsHub Logo
Followers 15
Posts 673
Boards Moderated 0
Alias Born 02/10/2010

Re: fafa48 post# 342

Sunday, 11/23/2014 2:00:49 PM

Sunday, November 23, 2014 2:00:49 PM

Post# of 639
Merck sold their vaccine division in 2013 which means they cut back their development efforts. They still have the means to help with the mass production of Newlinks VSV-EBOV. I think its interesting that there is a tie with GSK, since there was chatter last week that said Newlink and GSK may join forces for a more effective solution.